Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis

Kolev, Mirjam; Diem, Stefan; Diem, Lara; G. Rodrigues, Susana; Berzigotti, Annalisa; Stirnimann, Guido; Semmo, Nasser (2022). Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis. Journal of translational autoimmunity, 5, p. 100172. Elsevier 10.1016/j.jtauto.2022.100172

[img]
Preview
Text
1-s2.0-S2589909022000338-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (984kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Kolev, Mirjam, Diem, Stefan, Diem, Lara, Gomes Rodrigues, Susana, Berzigotti, Annalisa, Stirnimann, Guido, Semmo, Nasser

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2589-9090

Publisher:

Elsevier

Language:

English

Submitter:

Rahel Fuhrer

Date Deposited:

30 Nov 2022 15:55

Last Modified:

05 Dec 2022 16:29

Publisher DOI:

10.1016/j.jtauto.2022.100172

BORIS DOI:

10.48350/175364

URI:

https://boris.unibe.ch/id/eprint/175364

Actions (login required)

Edit item Edit item
Provide Feedback